Polymerase chain reaction (PCR) and real-time polymerase chain reaction (PCR) testing market comprises of sales of PCR, real time PCR testing services & related products. Polymerase chain reaction (PCR) & Real time Polymerase chain reaction (PCR) testing establishments construct, develop/deploy the related devices, reagents & services, to detect or measure the DNA (or RNA) in a sample. It finds its applications in mutation testing, cloning, genotyping, sequencing, paternity testing, and microarrays.
Early detection plays a vital role in treating Covid-19 patients. Real time RT-PCR technique is an extremely sensitive & specific testing method that can deliver the reliable diagnosis in as fast as three hours. Real time RT-PCR is considerably faster and has a lower potential for contamination as the entire process is within the closed tube. Hence, it is considered to be the most precise method available for detection of the corona-virus or Covid-19. This has created massive demand for PCR testing kits.
According to study, “Polymerase Chain Reaction (PCR) And Real-time Polymerase Chain Reaction (PCR) Testing Global Market Report 2020-30: Covid 19 Implications and Growth” the key companies operating in the global Polymerase Chain Reaction (PCR) And Real-time Polymerase Chain Reaction (PCR) market are Biomerieux Sa, Bio-Rad Laboratories, Abbott Laboratories, Agilent Technologies Inc., F.Hoffmann-La Roche Ltd (Roche Diagnostics), Thermo Fisher Scientific, Inc., Qiagen N.V., Genmark Diagnostics, General Electric Company (Ge Healthcare), Luminex Corporation, Danaher, Becton Dickinson And Company, Meridian Bioscience.
Based on offering, Polymerase Chain Reaction (PCR) And Real-time Polymerase Chain Reaction (PCR) market is segregated as assay, instruments, panels & consumables, reagents, accessories and software. Based on application, market is segregated as microRNA analysis, virus & bacterial analysis, fish species detection and microplasma species detection. In addition, based on end-user, market is segregated as pharmaceuticals, healthcare, agriculture and others.
The Polymerase Chain Reaction (PCR) And Real-time Polymerase Chain Reaction (PCR) market is driven by increase in population base for chronic disease patients, followed by growth in technological advancements in the field of life science, rise in incidence of infectious disease & genetic disorders and increase in public-private funds, investments, and grants for PCR-based research. However, high cost of PCR instruments and development of alternative technologies may impact the market. Moreover, rise in shift from plant-derived to genome-based drug discovery and increase in market penetration in emerging countries is key opportunities for market.
Based on geography, the North-American region dominates the global Polymerase Chain Reaction (PCR) And Real-time Polymerase Chain Reaction (PCR) market owing to strong presence of major PCR manufacturers and rise in demand for rapid diagnostic tests in the region. The Asian-Pacific and North-American regions are estimated to witness higher growth rate due to increase in the patient pool due to occurrence of chronic & infectious diseases over the forecast period. It is predicted that future of the global market will be bright as a result of expansion of its application areas coupled with increase is accuracy & precision during the forecast period. It is also predicted that the global Polymerase Chain Reaction (PCR) And Real-time Polymerase Chain Reaction (PCR) market will be reached at US $10.1 billion by 2023, at a CAGR of 7.9%.
For More Information, Click on the Link Below:-
Ankur Gupta, Head Marketing & Communications